Srinivas Akkaraju

Insider Reports History

Location
565 Everett Avenue, Palo Alto, CA
Signature
/s/ Srinivas Akkaraju
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Srinivas Akkaraju:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Scholar Rock Holding Corp Director Common Stock 5.3M $197M $37.24 Oct 3, 2025 Samsara BioCapital, L.P.
Mineralys Therapeutics, Inc. Director Common Stock 5.67M $86.4M $15.22 Sep 4, 2025 By Samsara BioCapital, L.P.
vTv Therapeutics Inc. Director Pre-Funded Warrants (Right to Buy) 1.55M $23.2M $15.00 Sep 22, 2025 By Samsara BioCapital, L.P.
ALUMIS INC. Director Common Stock 4.49M $20.7M $4.61 Nov 13, 2025 By Samsara BioCapital, L.P.
Scholar Rock Holding Corp Director Common Stock 500K $19.8M $39.52 Oct 6, 2025 By Samsara Opportunity Fund, L.P.
Mineralys Therapeutics, Inc. Director Common Stock 588K $15M $25.50 Sep 4, 2025 By Samsara Opportunity Fund, L.P.
vTv Therapeutics Inc. Director Warrant (Right to Buy) 983K $14.7M $15.00 Sep 22, 2025 By Samsara Opportunity Fund, L.P.
vTv Therapeutics Inc. Director Pre-Funded Warrants (Right to Buy) 877K $13.2M $15.00 Sep 22, 2025 By Samsara Opportunity Fund, L.P.
vTv Therapeutics Inc. Director Pre-Funded Warrants (Right to Buy) 1.55M $10.5M $11.80 Sep 3, 2025 Samsara BioCapital, L.P.
vTv Therapeutics Inc. Director Warrant (Right to Buy) 656K $9.83M $15.00 Sep 22, 2025 By Samsara BioCapital, L.P
vTv Therapeutics Inc. Director Class A Common Stock 207K $3.1M $15.00 Sep 22, 2025 By Samsara BioCapital, L.P.
vTv Therapeutics Inc. Director Class A Common Stock 106K $1.62M $15.27 Sep 22, 2025 By Samsara Opportunity Fund, L.P.
ALUMIS INC. Director Common Stock 276K $1.45M $5.25 Nov 13, 2025 By Samsara Opportunity Fund, L.P.
Scholar Rock Holding Corp Director Common Stock 21.1K $787K $37.24 Oct 3, 2025 Direct
vTv Therapeutics Inc. Director Director stock option (right to buy) 11K $182K $16.59 Jun 10, 2025 Direct
Allovir, Inc. Director, 10%+ Owner Common Stock 3.58K $36.1K $10.08 Mar 18, 2025 Indirect
Syros Pharmaceuticals, Inc. Director Common Stock 9.33K $15.6K $1.68 Sep 16, 2024 Direct
Syros Pharmaceuticals, Inc. Director Restricted Stock Units 2.67K $4.47K $1.68 Sep 16, 2024 Direct
Jiya Acquisition Corp. Director, 10%+ Owner Class B Common Stock 2.44M Sep 23, 2022 Indirect
vTv Therapeutics Inc. Director Warrant to Purchase Class A Common Stock (Right to Buy) 656K Sep 3, 2025 By Samsara BioCapital, L.P.
ALUMIS INC. Director Stock Option (Right to Buy) 49.8K Jul 30, 2025 Direct
Mineralys Therapeutics, Inc. Director Stock Option 32.9K Feb 13, 2025 Direct
Kalaris Therapeutics, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 18K Apr 10, 2025 Direct
Scholar Rock Holding Corp Director Stock Option (Right to Buy) 9.21K May 22, 2025 Direct
Syros Pharmaceuticals, Inc. Director Stock Option (right to buy) 6K Jun 5, 2024 Direct
CHINOOK THERAPEUTICS, INC. Director Common Stock 0 $39.03 Aug 11, 2023 By Samsara BioCapital, L.P.
CHINOOK THERAPEUTICS, INC. Director Common Stock 0 $39.03 Aug 11, 2023 Direct
CHINOOK THERAPEUTICS, INC. Director Restricted Stock Units 0 May 26, 2023 Direct
CHINOOK THERAPEUTICS, INC. Director Stock Option (Right to Buy) 0 $26.12 Aug 11, 2023 Direct
INTERCEPT PHARMACEUTICALS, INC. Director Common Stock 0 $19.00 Nov 8, 2023 Direct
INTERCEPT PHARMACEUTICALS, INC. Director Common Stock 0 $19.00 Nov 8, 2023 Indirect
INTERCEPT PHARMACEUTICALS, INC. Director Option to Purchase Common Stock 0 Nov 8, 2023 Direct

Insider Reports Filed by Srinivas Akkaraju

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALMS ALUMIS INC. Nov 13, 2025 1 $1.45M 4 Nov 17, 2025 Director
SRRK Scholar Rock Holding Corp Oct 3, 2025 6 $18.8M 4 Oct 7, 2025 Director
VTVT vTv Therapeutics Inc. Sep 22, 2025 3 $1.62M 4 Sep 25, 2025 Director
MLYS Mineralys Therapeutics, Inc. Sep 4, 2025 1 $15M 4 Sep 8, 2025 Director
VTVT vTv Therapeutics Inc. Sep 3, 2025 2 $0 4 Sep 5, 2025 Director
ALMS ALUMIS INC. Jul 30, 2025 1 $0 4 Aug 1, 2025 Director
VTVT vTv Therapeutics Inc. Jun 10, 2025 1 $66.4K 4 Jun 12, 2025 Director
SRRK Scholar Rock Holding Corp May 22, 2025 2 $0 4 May 23, 2025 Director
ALMS ALUMIS INC. May 21, 2025 1 $0 4 May 23, 2025 Director
ALMS ALUMIS INC. May 2, 2025 3 $1.48M 4 May 6, 2025 Director
KLRS Kalaris Therapeutics, Inc. Apr 10, 2025 1 $0 4 Apr 11, 2025 Director, 10%+ Owner
KLRS Kalaris Therapeutics, Inc. Mar 18, 2025 0 $0 3/A Mar 26, 2025 Director, 10%+ Owner
KLRS Kalaris Therapeutics, Inc. Mar 18, 2025 1 $0 4 Mar 18, 2025 Director, 10%+ Owner
MLYS Mineralys Therapeutics, Inc. Mar 13, 2025 1 $8.1M 4 Mar 17, 2025 Director
MLYS Mineralys Therapeutics, Inc. Feb 13, 2025 1 $0 4 Feb 24, 2025 Director, 10%+ Owner
SRRK Scholar Rock Holding Corp Oct 7, 2024 3 -$34.4M 4 Oct 7, 2024 Director
SYRS Syros Pharmaceuticals, Inc. Sep 16, 2024 2 $0 4 Sep 18, 2024 Director
ALMS ALUMIS INC. Jul 1, 2024 1 $25M 4/A Aug 27, 2024 Director
SRRK Scholar Rock Holding Corp Jun 27, 2024 2 $0 4 Jul 1, 2024 Director
ALMS ALUMIS INC. Jun 27, 2024 0 $0 3 Jun 27, 2024 Director
VTVT vTv Therapeutics Inc. Jun 25, 2024 2 $55.7K 4 Apr 24, 2025 Director
SYRS Syros Pharmaceuticals, Inc. Jun 5, 2024 2 $0 4 Jun 7, 2024 Director
SYRS Syros Pharmaceuticals, Inc. Jun 1, 2024 2 $0 4 Jun 4, 2024 Director
MLYS Mineralys Therapeutics, Inc. May 22, 2024 1 $0 4 May 23, 2024 Director, 10%+ Owner
VTVT vTv Therapeutics Inc. Mar 5, 2024 2 $0 4 Dec 6, 2024 Director, 10%+ Owner
VTVT vTv Therapeutics Inc. Feb 27, 2024 1 $0 4 Jun 13, 2024 Director, 10%+ Owner
VTVT vTv Therapeutics Inc. Feb 27, 2024 2 $12.5M 4 Feb 29, 2024 Director, 10%+ Owner
VTVT vTv Therapeutics Inc. Feb 23, 2024 0 $0 3 Feb 29, 2024 Director, 10%+ Owner
MLYS Mineralys Therapeutics, Inc. Feb 12, 2024 1 $7.5M 4 Feb 14, 2024 Director, 10%+ Owner
SYRS Syros Pharmaceuticals, Inc. Dec 21, 2023 1 $4M 4 Dec 26, 2023 Director
ICPT INTERCEPT PHARMACEUTICALS, INC. Nov 8, 2023 13 -$13M 4 Nov 13, 2023 Director
SRRK Scholar Rock Holding Corp Oct 16, 2023 1 $15M 4 Oct 18, 2023 Director, 10%+ Owner
SYRS Syros Pharmaceuticals, Inc. Sep 16, 2023 2 $0 4 Sep 19, 2023 Director
KDNY CHINOOK THERAPEUTICS, INC. Aug 11, 2023 5 -$1.08M 4 Aug 11, 2023 Director
SRRK Scholar Rock Holding Corp Jun 21, 2023 1 $0 4 Jun 22, 2023 Director
SYRS Syros Pharmaceuticals, Inc. Jun 1, 2023 2 $0 4 Jun 2, 2023 Director
KDNY CHINOOK THERAPEUTICS, INC. May 26, 2023 2 $0 4 May 31, 2023 Director
ICPT INTERCEPT PHARMACEUTICALS, INC. May 24, 2023 2 $0 4 May 25, 2023 Director
MLYS Mineralys Therapeutics, Inc. Feb 14, 2023 4 $15M 4 Feb 16, 2023 Director, 10%+ Owner
MLYS Mineralys Therapeutics, Inc. Feb 9, 2023 1 $0 4 Feb 13, 2023 Director, 10%+ Owner
MLYS Mineralys Therapeutics, Inc. Feb 9, 2023 0 $0 3 Feb 9, 2023 Director, 10%+ Owner
JYAC Jiya Acquisition Corp. Sep 23, 2022 1 $0 4 Sep 23, 2022 Director, 10%+ Owner
SYRS Syros Pharmaceuticals, Inc. Sep 16, 2022 4 $0 4/A Apr 20, 2023 Director
SRRK Scholar Rock Holding Corp Sep 16, 2022 1 $0 4 Sep 20, 2022 Director
SRRK Scholar Rock Holding Corp Jul 26, 2022 0 $0 3 Jul 28, 2022 Director
SYRS Syros Pharmaceuticals, Inc. Jun 1, 2022 1 $0 4 Jun 2, 2022 Director
KDNY CHINOOK THERAPEUTICS, INC. May 27, 2022 1 $7.98M 4 Jun 1, 2022 Director
KDNY CHINOOK THERAPEUTICS, INC. May 26, 2022 2 $0 4 May 31, 2022 Director
ICPT INTERCEPT PHARMACEUTICALS, INC. May 25, 2022 2 $0 4 May 27, 2022 Director
KDNY CHINOOK THERAPEUTICS, INC. Nov 15, 2021 1 $17M 4 Nov 17, 2021 Director
JYAC Jiya Acquisition Corp. Sep 23, 2021 2 $0 4 Sep 27, 2021 Director, 10%+ Owner
JYAC Jiya Acquisition Corp. Aug 26, 2021 1 $0 4 Aug 30, 2021 Director, 10%+ Owner
KDNY CHINOOK THERAPEUTICS, INC. Aug 18, 2021 1 $2.5M 4 Aug 20, 2021 Director
SYRS Syros Pharmaceuticals, Inc. Jun 8, 2021 1 $0 4 Jun 10, 2021 Director
KDNY CHINOOK THERAPEUTICS, INC. Jun 4, 2021 1 $0 4 Jun 8, 2021 Director
ICPT INTERCEPT PHARMACEUTICALS, INC. May 27, 2021 2 $0 4 Jun 1, 2021 Director